Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285392882> ?p ?o ?g. }
- W4285392882 endingPage "944" @default.
- W4285392882 startingPage "927" @default.
- W4285392882 abstract "The pivotal PACIFIC trial defined durvalumab consolidation as the new standard of care in patients with stage III non-small-cell lung cancer treated with definitive radiochemotherapy. The authors characterized the durvalumab effect after induction chemotherapy according to the ESPATUE trial and definitive radiochemotherapy. All consecutive patients with stage III non-small-cell lung cancer receiving definitive radiochemotherapy between January 2017 and February 2020 were included. Primary end points were progression-free survival and overall survival. Altogether, 160 patients (75 PD-L1-positive, 62 PD-L1-negative, 23 unknown) received definitive radiochemotherapy, 146 (91%) of whom received prior induction chemotherapy. Durvalumab consolidation showed high effectiveness overall and in the good-risk group according to the PACIFIC trial (log-rank test: p < 0.005). Hazard ratios for progression-free survival and overall survival were at the lower limits of those in the PACIFIC trial. These results were robust to adjustment for potential confounders by propensity score weighting. Eastern Cooperative Oncology Group (ECOG) performance status was the most important pretreatment prognostic factor." @default.
- W4285392882 created "2022-07-14" @default.
- W4285392882 creator A5000688820 @default.
- W4285392882 creator A5006830341 @default.
- W4285392882 creator A5034451063 @default.
- W4285392882 creator A5036507802 @default.
- W4285392882 creator A5037650981 @default.
- W4285392882 creator A5040777787 @default.
- W4285392882 creator A5044483876 @default.
- W4285392882 creator A5046955303 @default.
- W4285392882 creator A5047006205 @default.
- W4285392882 creator A5053012967 @default.
- W4285392882 creator A5071494218 @default.
- W4285392882 creator A5074439466 @default.
- W4285392882 creator A5075140523 @default.
- W4285392882 creator A5075896912 @default.
- W4285392882 creator A5079084775 @default.
- W4285392882 creator A5082059315 @default.
- W4285392882 creator A5083358107 @default.
- W4285392882 creator A5086393240 @default.
- W4285392882 date "2022-08-01" @default.
- W4285392882 modified "2023-10-14" @default.
- W4285392882 title "Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors" @default.
- W4285392882 cites W1968899146 @default.
- W4285392882 cites W1974833109 @default.
- W4285392882 cites W1998821185 @default.
- W4285392882 cites W2044673415 @default.
- W4285392882 cites W2075776770 @default.
- W4285392882 cites W2102520493 @default.
- W4285392882 cites W2122532950 @default.
- W4285392882 cites W2133223019 @default.
- W4285392882 cites W2140075859 @default.
- W4285392882 cites W2158708198 @default.
- W4285392882 cites W2228221433 @default.
- W4285392882 cites W2346291869 @default.
- W4285392882 cites W2528393079 @default.
- W4285392882 cites W2753065806 @default.
- W4285392882 cites W2893824814 @default.
- W4285392882 cites W2913897486 @default.
- W4285392882 cites W2946266742 @default.
- W4285392882 cites W2952508886 @default.
- W4285392882 cites W2976744492 @default.
- W4285392882 cites W2981703949 @default.
- W4285392882 cites W2990455178 @default.
- W4285392882 cites W3011596192 @default.
- W4285392882 cites W3015017936 @default.
- W4285392882 cites W3023345306 @default.
- W4285392882 cites W3028746215 @default.
- W4285392882 cites W3082586784 @default.
- W4285392882 cites W3084595155 @default.
- W4285392882 cites W3094020015 @default.
- W4285392882 cites W3107733830 @default.
- W4285392882 cites W3107857442 @default.
- W4285392882 cites W3108819942 @default.
- W4285392882 cites W3110482491 @default.
- W4285392882 cites W3112865499 @default.
- W4285392882 cites W3126187431 @default.
- W4285392882 cites W3127357052 @default.
- W4285392882 cites W3129152618 @default.
- W4285392882 cites W3132841322 @default.
- W4285392882 cites W3148827278 @default.
- W4285392882 cites W3149412548 @default.
- W4285392882 cites W3160287582 @default.
- W4285392882 cites W3160396906 @default.
- W4285392882 cites W3166324988 @default.
- W4285392882 cites W3191201838 @default.
- W4285392882 cites W3203773970 @default.
- W4285392882 cites W3216370963 @default.
- W4285392882 cites W4226175083 @default.
- W4285392882 doi "https://doi.org/10.2217/imt-2021-0341" @default.
- W4285392882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35822656" @default.
- W4285392882 hasPublicationYear "2022" @default.
- W4285392882 type Work @default.
- W4285392882 citedByCount "4" @default.
- W4285392882 countsByYear W42853928822023 @default.
- W4285392882 crossrefType "journal-article" @default.
- W4285392882 hasAuthorship W4285392882A5000688820 @default.
- W4285392882 hasAuthorship W4285392882A5006830341 @default.
- W4285392882 hasAuthorship W4285392882A5034451063 @default.
- W4285392882 hasAuthorship W4285392882A5036507802 @default.
- W4285392882 hasAuthorship W4285392882A5037650981 @default.
- W4285392882 hasAuthorship W4285392882A5040777787 @default.
- W4285392882 hasAuthorship W4285392882A5044483876 @default.
- W4285392882 hasAuthorship W4285392882A5046955303 @default.
- W4285392882 hasAuthorship W4285392882A5047006205 @default.
- W4285392882 hasAuthorship W4285392882A5053012967 @default.
- W4285392882 hasAuthorship W4285392882A5071494218 @default.
- W4285392882 hasAuthorship W4285392882A5074439466 @default.
- W4285392882 hasAuthorship W4285392882A5075140523 @default.
- W4285392882 hasAuthorship W4285392882A5075896912 @default.
- W4285392882 hasAuthorship W4285392882A5079084775 @default.
- W4285392882 hasAuthorship W4285392882A5082059315 @default.
- W4285392882 hasAuthorship W4285392882A5083358107 @default.
- W4285392882 hasAuthorship W4285392882A5086393240 @default.
- W4285392882 hasBestOaLocation W42853928821 @default.
- W4285392882 hasConcept C121608353 @default.
- W4285392882 hasConcept C126322002 @default.
- W4285392882 hasConcept C143998085 @default.